CEO
Fabian Tenenbaum
Employees
27
Industry
Pharmaceutical Preparation Manufacturing
bellerophon therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.
Loading...
Open
0.04
Mkt cap
453K
Volume
109
High
0.04
P/E Ratio
-0.04
52-wk high
0.10
Low
0.04
Div yield
N/A
52-wk low
0.03
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.